VERITY
LIVE

Serial Number

88400241

Owner

Verity Solutions Group, Inc.

Attorney

Lynne E. Graybeal

Filing Date

Apr 24, 2019

Add to watchlist:

No watchlists yet
View on USPTO

VERITY Trademark

Serial Number: 88400241

VERITY is a trademark filed by Verity Solutions Group, Inc. on April 24, 2019. The trademark is classified under Class 36 (Insurance & Financial), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 45 (Legal & Security Services), Class 16 (Paper Goods), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Verity Solutions Group, Inc. (14 trademarks)

Suite 200 12131 113th Avenue NE
Kirkland, WA 98034

Entity Type: 03

Trademark Details

Filing Date

April 24, 2019

Registration Date

Not Registered

Published for Opposition

February 13, 2024

Goods & Services

Advisory and consulting services in the field of cost management of health care and pharmaceuticals; Business advisory and consulting services in the field of health care and pharmaceutical benefit programs; pharmaceutical cost management advisory and consulting services regarding the administration of the federal 340B prescription drug discount program and maximization of benefits; providing an online computer database for collecting and reporting pharmacy management and drug dispensing information for business purposes; data management services, namely, electronic data collection, online claims management, and financial reconciliation of accounts on behalf of others; administration coordination services in the nature of facilitating administrative coordination between health care facilities, pharmacies, and insurance plans; inventory management; Business consulting services in the fields of the business management and administration of Federal 340B pharmacy programs and discount prescription drug programs; business management and administration of Federal 340B pharmaceutical programs and discount prescription drug programs; Business and Inventory management services provided to eligible organizations in the healthcare fields for controlling drug inventories; business and inventory management services provided to eligible pharmacies for controlling drug inventories; business assistance, advisory services, and consultancy in the field of assisting others in preparing and filing applications for eligible health care facilities and pharmacies in the fields of Federal 340B pharmaceutical programs and discount prescription drug programs with governmental regulatory bodies for business purposes; business consulting services, relating to operations management services, managing the flow of inventory, business information, and accounts receivable billing between health centers, pharmacies, wholesalers, and insurance companies; business assistance, advisory services, and consultancy, namely, assisting others in preparing and filing applications for eligible health care facilities and pharmacies in the fields of Federal 340B pharmaceutical programs and discount prescription drug programs with governmental regulatory bodies for business purposes; audit support services, namely, audit policy and procedures guidance, review of audit documents, data and procedures, preparation, organization, and presentation of the documents and data requested by a government body or third party, and providing business advice on government or third party audit processes, policies, and strategies; specialty retail pharmacy services; interactive record-keeping services for use in regulatory compliance by professionals in the healthcare, medical and pharmaceutical fields; consulting services in the field of pharmaceutical cost management services and drug utilization review services; business consulting services in the fields of pharmacy and prescription medication benefits; business consulting services in the field of healthcare benefits

Medical identification cards, not magnetically encoded; medical identification cards, not magnetically encoded for use in connection with payment for prescription medication; discount prescription drug cards, not magnetically encoded

Advisory and consulting services in the field of health care; Medical and pharmaceutical consultation

Regulatory compliance consulting in the fields of healthcare, pharmaceutical, Federal 340B pharmacy programs, and discount prescription drug programs; regulatory compliance consulting services in the fields of healthcare, pharmaceuticals and Federal 340B pharmaceutical program in the nature of compliance, auditing, and reviewing contracts, systems, procedures, and policies, all for compliance with government regulations; reviewing standards and practices to assure compliance with laws and regulations relating to healthcare and pharmaceutical benefit plans; regulatory compliance consulting in the field of assisting others in preparing and filing applications for eligible health care facilities and pharmacies in the fields of Federal 340B pharmaceutical programs and discount prescription drug programs with governmental regulatory bodies; advisory and consulting services in the field of health care and pharmaceutical regulatory compliance

Advisory and consulting services in the field of pharmaceutical benefit management services; Health care and pharmacy benefits claims recovery services in the nature of insurance subrogation, namely, coordination of insurance benefits programs claims processing and administration; Insurance administration services, namely, insurance subrogation and assisting others with collecting insurance premiums in the nature of the collection of money owed by patients and insurance providers; pharmacy benefit management services; pharmacy benefit and claims processing management services; financial consulting services in the fields of healthcare benefits; financial consulting services in the fields of pharmacy and prescription medication benefits; consulting services in the field of pharmaceutical benefit management services; consulting services in the field of pharmaceutical benefit management services of Federal 340B pharmacy programs, and discount prescription drug programs

Software as a Service (SAAS) services featuring software for use with managing medical and pharmaceutical records and data; computer services, namely, providing search engine services for obtaining and managing medical and pharmaceuticals records and data on a global computer network; Software as a Service (SAAS) services featuring software for cost management in the field of health care and pharmaceuticals; software as a service (SAAS) services featuring software for use with self-auditing company records to ensure compliance with, and maximizing the benefits of, health care and pharmaceutical benefit programs; software as a service (SAAS) services featuring software for administering and maximizing the use of the federal 340B prescription drug discount program through organization of information and implementation of automated duty allocation, automated risk scoring, and expert-defined tasks and assessment steps

Filing History

TEAS STATEMENT OF USE RECEIVED
Feb 24, 2026 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 21, 2026 EXRA
SOU EXTENSION 4 GRANTED
Feb 20, 2026 EX4G
SOU EXTENSION 4 FILED
Feb 20, 2026 EXT4
SOU TEAS EXTENSION RECEIVED
Feb 20, 2026 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 7, 2025 EXRA
SOU EXTENSION 3 GRANTED
Oct 6, 2025 EX3G
SOU EXTENSION 3 FILED
Oct 6, 2025 EXT3
SOU TEAS EXTENSION RECEIVED
Oct 6, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 12, 2025 EXRA
SOU EXTENSION 2 GRANTED
Mar 11, 2025 EX2G
SOU EXTENSION 2 FILED
Mar 11, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Mar 11, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 8, 2024 EXRA
SOU EXTENSION 1 GRANTED
Oct 8, 2024 EX1G
SOU EXTENSION 1 FILED
Oct 8, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Oct 8, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 9, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 13, 2024 NPUB
PUBLISHED FOR OPPOSITION
Feb 13, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 24, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 5, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 5, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 5, 2024 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Nov 22, 2023 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
May 26, 2023 GNS3
LETTER OF SUSPENSION E-MAILED
May 26, 2023 GNSL
SUSPENSION LETTER WRITTEN
May 26, 2023 CNSL
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Apr 18, 2023 GNS3
LETTER OF SUSPENSION E-MAILED
Apr 18, 2023 GNSL
SUSPENSION LETTER WRITTEN
Apr 18, 2023 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 17, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 16, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 16, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 20, 2022 GNRN
NON-FINAL ACTION E-MAILED
Dec 20, 2022 GNRT
NON-FINAL ACTION WRITTEN
Dec 20, 2022 CNRT
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Nov 8, 2022 GNS3
LETTER OF SUSPENSION E-MAILED
Nov 8, 2022 GNSL
SUSPENSION LETTER WRITTEN
Nov 8, 2022 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 4, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 4, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 4, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 10, 2022 GNRN
NON-FINAL ACTION E-MAILED
Aug 10, 2022 GNRT
NON-FINAL ACTION WRITTEN
Aug 10, 2022 CNRT
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Mar 9, 2022 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Aug 13, 2021 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jan 21, 2021 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Jun 29, 2020 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Dec 6, 2019 GNS3
LETTER OF SUSPENSION E-MAILED
Dec 6, 2019 GNSL
SUSPENSION LETTER WRITTEN
Dec 6, 2019 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 14, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 14, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 14, 2019 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 13, 2019 GNRN
NON-FINAL ACTION E-MAILED
Jun 13, 2019 GNRT
NON-FINAL ACTION WRITTEN
Jun 13, 2019 CNRT
ASSIGNED TO EXAMINER
Jun 5, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 9, 2019 NWOS
NEW APPLICATION ENTERED
Apr 27, 2019 NWAP